Article
Fluoropyrimidine Cardiotoxicity: Role of Uridine Triacetate and Pharmacogenomic Insights from a Case of 5-FU-Induced Cardiogenic Shock.
Journal of cardiovascular pharmacology - 1 Sept 2026
Filomia Simone, Del Buono Marco G, Saponara Gianluigi, Aurigemma Cristina, Marano Riccardo, Moliterno Eleonora, Tortora Giampaolo, Minucci Angelo, Salvatore Lisa, Soave Paolo M, Burzotta Francesco, Sanna Tommaso
Abstract excerpt
ABSTRACT: Fluoropyrimidines, including 5-fluorouracil and capecitabine, are widely used antimetabolite agents and remain central to the treatment of several solid tumors, particularly gastrointestinal malignancies. However, they are a well-established cause of chemotherapy-related cardiotoxicity. Although coronary vasospasm is the best recognized manifestation, fluoropyrimidine cardiotoxicity encompasses a broad...
Read the complete abstract on PubMedTopics
- Humans
- Female
- Shock, Cardiogenic
- Cardiotoxicity
- Fluorouracil
